Aurothiomalate
Aurlumyn is a brand-name medication. Limited information is available about this drug, as specific details regarding its mechanism of action, indications, and usage have not been specified or are not within the available medical knowledge base.
Aurlumyn is a brand-name medication; specific therapeutic details are not currently available.
Key facts at a glance
- RxNorm
- 2680305
- Generic
- Aurlumyn
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Specific indications for Aurlumyn have not been specified or verified.
Mechanism of action has not been specified for this medication.
Consult a healthcare provider or pharmacist for accurate and up-to-date information about this medication, as specific safety data and usage guidelines are not currently available.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed September 3, 2026. · Read our editorial policy